Inogen Inc (INGN) is a publicly traded Healthcare sector company. As of November 5, 2026, INGN trades at $6.74 with a market cap of $191.61M and a P/E ratio of -6.55. INGN moved -7.06% today. Year to date, INGN is +8.41%; over the trailing twelve months it is -10.56%. Its 52-week range spans $5.05 to $9.13. Analyst consensus is buy with an average price target of $13.00. Rallies surfaces INGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover INGN: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $13.00.
| Metric | Value |
|---|---|
| Price | $6.74 |
| Market Cap | $191.61M |
| P/E Ratio | -6.55 |
| EPS | $-0.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.13 |
| 52-Week Low | $5.05 |
| Volume | 186.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $354.30M |
| Net Income | $-24.59M |
| Gross Margin | 44.51% |
2 analysts cover INGN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.00.